Literature DB >> 29689419

Synthesis and molecular docking study of piperazine derivatives as potent urease inhibitors.

Muhammad Taha1, Abdul Wadood2.   

Abstract

Urease is known to be one of the major causes of diseases induced by Helicobacter pylori, thus allow them to survive at low pH inside the stomach and thereby, play an important role in the pathogenesis of gastric and peptic ulcer, apart from cancer as well. Keeping in view the great importance of urease inhibitors, here in this study we have synthesized piperazine derivatives (1-15) and evaluated for their urease inhibitory activity. All analogs showed excellent inhibitory potential with IC50 values ranging between 1.1 ± 0.01 and 33.40 ± 1.50 µM when compared with the standard inhibitor thiourea (IC50 = 21.30 ± 1.10 µM). Structure activity relationship has been established for all compounds which are mainly based upon the substitution on phenyl ring. Molecular docking study was performed in order to understand the binding interaction of the compounds in the active site of enzyme.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Molecular docking study; Piperazine; Synthesis; Urease inhibition

Mesh:

Substances:

Year:  2018        PMID: 29689419     DOI: 10.1016/j.bioorg.2018.04.007

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  2 in total

1.  New Triazinoindole Bearing Benzimidazole/Benzoxazole Hybrids Analogs as Potent Inhibitors of Urease: Synthesis, In Vitro Analysis and Molecular Docking Studies.

Authors:  Sundas Mumtaz; Shahid Iqbal; Mazloom Shah; Rafaqat Hussain; Fazal Rahim; Wajid Rehman; Shoaib Khan; Obaid-Ur-Rahman Abid; Liaqat Rasheed; Ayed A Dera; Hanan A Al-Ghulikah; Sana Kehili; Eslam B Elkaeed; Hamad Alrbyawi; Mohammed Issa Alahmdi
Journal:  Molecules       Date:  2022-10-04       Impact factor: 4.927

2.  N-monoarylacetothioureas as potent urease inhibitors: synthesis, SAR, and biological evaluation.

Authors:  Wei-Yi Li; Wei-Wei Ni; Ya-Xi Ye; Hai-Lian Fang; Xing-Ming Pan; Jie-Ling He; Tian-Li Zhou; Juan Yi; Shan-Shan Liu; Mi Zhou; Zhu-Ping Xiao; Hai-Liang Zhu
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.